Pharmerging Market: Industry Trends, Share, Size, Growth and Forecast 2021-2026

According to IMARC Group’s latest report, titled “Pharmerging Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026," the global pharmerging market grew at a CAGR of 16% during 2015-2020. Looking forward, the market is expected to continue its strong growth during 2021-2026.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Pharmerging stands for a group of countries that hold low positioning in the pharmaceutical market but have a speedy growth pace. These countries primarily include Brazil, South Africa, India, Russia, etc. The product segment that is considered in the analysis of the pharmerging countries includes a wide range of pharmaceutical and healthcare products. Some of the common pharma products include generic prescription drugs, patent prescription drugs, and over-the-counter (OTC) drugs. On the other hand, numerous healthcare products comprise of medical devices, clinical diagnostics, healthcare IT and software services, etc.

Get Sample Report with Detail COVID-19 Impact Analysis -https://www.imarcgroup.com/pharmerging-market/requestsample

Market Trends

The rising healthcare expenditures along with the growing number of private hospitals are currently propelling the global pharmerging market. Additionally, the high prevalence of numerous chronic diseases and growing consumer awareness towards early disease detection and treatment procedures are further augmenting the market growth. Besides this, a significant growth in the medical tourism sector across the developing countries is further catalyzing the global market for pharmerging. In the coming years, the emergence of numerous advanced technologies, such as AI, IoT, predictive analytics, cloud computing, etc., in the healthcare sector will continue to drive the global market for pharmerging.

Buy Full Report with Detail Analysis with COVID-19 Impact – https://www.imarcgroup.com/pharmerging-market

List of Key Companies Covered in this Market Report:

• Sanofi S.A. (EPA: SAN)
• Pfizer Inc. (NYSE: PFE)
• AstraZeneca Plc (LON: AZN)
• GlaxoSmithKline Plc (LON: GSK)
• Hoffmann-La Roche AG (Roche AG) (SWX: RO)
• Eli Lilly and Company (NYSE: LLY)
• Johnson & Johnson (NYSE: JNJ)
• Abbott Laboratories (NYSE: ABT)
• Novartis AG (SWX: NOVN)
• Teva Pharmaceutical Limited. (TLV: TEVA)

The report has segmented the market on the basis of product outlook, indication, distribution channel and country.

Breakup by Product Outlook:

• Pharmaceuticals
  • Patented Prescription Drugs
  • Generic Prescription Drugs
  • OTC Drugs
• Healthcare
  • Medical Devices
  • Clinical Diagnosis
  • Others

Breakup by Indication:

• Lifestyle Diseases
• Cancer and Autoimmune Diseases
• Infectious Diseases
• Others

Breakup by Distribution Channel:

• Hospitals
• Retail Pharmacies
• Online Stores
• Others

Breakup by Country:

• Tier I
  • China
• Tier II
  • India
  • Brazil
  • Russia
  • South Africa
• Tier II
  • Argentina
  • Mexico
  • Poland
  • Ukraine
  • Turkey
  • Saudi Arabia
  • Egypt
  • Algeria
  • Nigeria
  • Thailand
  • Indonesia
  • Pakistan
  • Others

Key highlights of the report:

• Market Performance (2015-2020)
• Market Outlook (2021- 2026)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: sales@imarcgroup.com

Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800